GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,790.60p
   
  • Change Today:
      4.00p
  • 52 Week High: 1,824.40
  • 52 Week Low: 1,380.40
  • Currency: UK Pounds
  • Shares Issued: 5,084m
  • Volume: 2,807,487
  • Market Cap: 91,037m
  • RiskGrade: 129

GSK Overview

UK-based GSK Plc is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book n/a  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

GSK Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%
31-Dec-18 30,821.00 4,800.00 119.40p 12.5 1.8 +7% 80.00p 5.4%
31-Dec-19 33,754.00 6,221.00 123.90p 14.4 3.6 +4% 80.00p 4.5%
31-Dec-20 34,099.00 6,968.00 115.90p 11.6 n/a -6% 80.00p 6.0%
31-Dec-21 34,114.00 5,442.00 113.20p 14.2 n/a -2% 80.00p 5.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GSK Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-22 36,151.23 8,455.18 121.60p 14.7 2.0 +7% 52.27p 2.9%
31-Dec-23 37,226.22 9,277.35 130.39p 13.7 1.9 +7% 53.78p 3.0%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

GSK Company Announcements

Director/PDMR Shareholding 06-Jul-2022 10:11 RNS
GSK disclose discontinued operations from Q2 2022 05-Jul-2022 12:43 RNS
Director/PDMR Shareholding 05-Jul-2022 09:45 RNS

Latest GSK Director Deals

Traded Action Notifier PriceAmountValue
04-Jul-22 Transfer From Emma Walmsley 0.000p 7 0.00
04-Jul-22 Buy Emma Walmsley 1,798.94p 7 125.93
01-Jul-22 Buy Dividends Emma Walmsley 1,762.90p 20 352.58

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GSK Market Data

Currency UK Pounds
Share Price 1,790.60p
Change Today 4.00p
% Change 0.22 %
52 Week High 1,824.40
52 Week Low 1,380.40
Volume 2,807,487
Shares Issued 5,084m
Market Cap 91,037m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
81.19% above the market average81.19% above the market average81.19% above the market average81.19% above the market average81.19% above the market average
87.30% above the sector average87.30% above the sector average87.30% above the sector average87.30% above the sector average87.30% above the sector average
Income Not Available
Growth
71.43% below the market average71.43% below the market average71.43% below the market average71.43% below the market average71.43% below the market average
90% below the sector average90% below the sector average90% below the sector average90% below the sector average90% below the sector average

What The Brokers Say

Strong Buy 7
Buy 1
Neutral 12
Sell 0
Strong Sell 1
Total 21
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 19-May-22 24-Feb-22
Paid 01-Jul-22 07-Apr-22
Amount 14.00p 23.00p

Trades for 06-Jul-2022

Time Volume / Share Price
11:36 203 @ 1,790.40p
11:36 53 @ 1,790.60p
11:36 24 @ 1,790.60p
11:36 24 @ 1,790.60p
11:36 24 @ 1,790.60p

GSK Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page